questionsmedicales.fr
Thérapeutique
Traitement médicamenteux
Voies d'administration de substances chimiques et des médicaments
Injections
Injections sous-cutanées
Injections sous-cutanées : Questions médicales fréquentes
Diagnostic
5
Réaction d'hypersensibilité
Injections sous-cutanées
Tests de laboratoire
Injections sous-cutanées
Infection
Injections sous-cutanées
Douleur
Injections sous-cutanées
Surdosage
Injections sous-cutanées
Symptômes
5
Réaction locale
Injections sous-cutanées
Réaction d'hypersensibilité
Injections sous-cutanées
Infection
Injections sous-cutanées
Complications
Injections sous-cutanées
Lipodystrophie
Injections sous-cutanées
Prévention
5
Prévention des infections
Injections sous-cutanées
Pratiques médicales
Injections sous-cutanées
Douleur
Injections sous-cutanées
Éducation des patients
Injections sous-cutanées
Lipodystrophie
Injections sous-cutanées
Traitements
5
Antihistaminiques
Injections sous-cutanées
Antibiotiques
Injections sous-cutanées
Analgésiques
Injections sous-cutanées
Soins des plaies
Injections sous-cutanées
Prévention des infections
Injections sous-cutanées
Complications
5
Complications
Injections sous-cutanées
Lipodystrophie
Injections sous-cutanées
Infection
Injections sous-cutanées
Complications
Injections sous-cutanées
Cicatrices
Injections sous-cutanées
Facteurs de risque
5
Facteurs de risque
Infections
Diabète
Injections sous-cutanées
Anticoagulants
Injections sous-cutanées
Âge
Injections sous-cutanées
Obésité
Injections sous-cutanées
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Injections sous-cutanées : Questions médicales les plus fréquentes",
"headline": "Injections sous-cutanées : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Injections sous-cutanées : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-10",
"dateModified": "2026-01-30",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Injections sous-cutanées"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Injections",
"url": "https://questionsmedicales.fr/mesh/D007267",
"about": {
"@type": "MedicalCondition",
"name": "Injections",
"code": {
"@type": "MedicalCode",
"code": "D007267",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.319.267.530"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Injections intradermiques",
"alternateName": "Injections, Intradermal",
"url": "https://questionsmedicales.fr/mesh/D007271",
"about": {
"@type": "MedicalCondition",
"name": "Injections intradermiques",
"code": {
"@type": "MedicalCode",
"code": "D007271",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.319.267.530.620.410"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Injections sans aiguille",
"alternateName": "Injections, Jet",
"url": "https://questionsmedicales.fr/mesh/D007277",
"about": {
"@type": "MedicalCondition",
"name": "Injections sans aiguille",
"code": {
"@type": "MedicalCode",
"code": "D007277",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.319.267.530.620.570"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Mésothérapie",
"alternateName": "Mesotherapy",
"url": "https://questionsmedicales.fr/mesh/D057748",
"about": {
"@type": "MedicalCondition",
"name": "Mésothérapie",
"code": {
"@type": "MedicalCode",
"code": "D057748",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.319.267.530.620.785"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Injections sous-cutanées",
"alternateName": "Injections, Subcutaneous",
"code": {
"@type": "MedicalCode",
"code": "D007279",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Arezoo M Ardekani",
"url": "https://questionsmedicales.fr/author/Arezoo%20M%20Ardekani",
"affiliation": {
"@type": "Organization",
"name": "School of Mechanical Engineering, Purdue University, West Lafayette, IN 47906, United States. Electronic address: ardekani@purdue.edu."
}
},
{
"@type": "Person",
"name": "Ehsan Rahimi",
"url": "https://questionsmedicales.fr/author/Ehsan%20Rahimi",
"affiliation": {
"@type": "Organization",
"name": "Mechanical Engineering, Purdue University, 585 Purdue Mall Purdue University West Lafayette, IND 47906, United States."
}
},
{
"@type": "Person",
"name": "Clairissa D Corpstein",
"url": "https://questionsmedicales.fr/author/Clairissa%20D%20Corpstein",
"affiliation": {
"@type": "Organization",
"name": "Department of Industrial and Physical Pharmacy, Purdue University, West Lafayette, Indiana, USA."
}
},
{
"@type": "Person",
"name": "Tonglei Li",
"url": "https://questionsmedicales.fr/author/Tonglei%20Li",
"affiliation": {
"@type": "Organization",
"name": "Department of Industrial and Physical Pharmacy, Purdue University, West Lafayette, Indiana, USA. tonglei@purdue.edu."
}
},
{
"@type": "Person",
"name": "Fudan Zheng",
"url": "https://questionsmedicales.fr/author/Fudan%20Zheng",
"affiliation": {
"@type": "Organization",
"name": "Industrial & Physical Pharmacy, Purdue University West Lafayette, Indiana, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Subcutaneous injections: A cross-sectional study of knowledge and practice preferences of nurses.",
"datePublished": "2023-05-04",
"url": "https://questionsmedicales.fr/article/37114438",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/10376178.2023.2209207"
}
},
{
"@type": "ScholarlyArticle",
"name": "SubQ-Sim: A Subcutaneous Physiologically Based Biopharmaceutics Model. Part 1: The Injection and System Parameters.",
"datePublished": "2023-08-27",
"url": "https://questionsmedicales.fr/article/37634241",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11095-023-03567-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Computational modeling of the effect of skin pinch and stretch on subcutaneous injection of monoclonal antibodies using autoinjector devices.",
"datePublished": "2023-08-01",
"url": "https://questionsmedicales.fr/article/37526775",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10237-023-01746-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Implementation strategies to scale up self-administered depot medroxyprogesterone acetate subcutaneous injectable contraception: a scoping review.",
"datePublished": "2023-07-04",
"url": "https://questionsmedicales.fr/article/37403147",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13643-023-02216-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Patient attitudes towards and satisfaction with subcutaneous injection of progesterone versus vaginal administration in assisted reproductive technology treatment.",
"datePublished": "2023-05-30",
"url": "https://questionsmedicales.fr/article/37269751",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ejogrb.2023.05.032"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Thérapeutique",
"item": "https://questionsmedicales.fr/mesh/D013812"
},
{
"@type": "ListItem",
"position": 3,
"name": "Traitement médicamenteux",
"item": "https://questionsmedicales.fr/mesh/D004358"
},
{
"@type": "ListItem",
"position": 4,
"name": "Voies d'administration de substances chimiques et des médicaments",
"item": "https://questionsmedicales.fr/mesh/D004333"
},
{
"@type": "ListItem",
"position": 5,
"name": "Injections",
"item": "https://questionsmedicales.fr/mesh/D007267"
},
{
"@type": "ListItem",
"position": 6,
"name": "Injections sous-cutanées",
"item": "https://questionsmedicales.fr/mesh/D007279"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Injections sous-cutanées - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Injections sous-cutanées",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-02-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Injections sous-cutanées",
"description": "Comment diagnostiquer une réaction à une injection sous-cutanée ?\nQuels tests peuvent évaluer l'efficacité d'une injection sous-cutanée ?\nQuels signes indiquent une infection au site d'injection ?\nComment évaluer une douleur persistante après injection ?\nQuels symptômes peuvent indiquer une surdose par injection ?",
"url": "https://questionsmedicales.fr/mesh/D007279#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Injections sous-cutanées",
"description": "Quels symptômes sont courants après une injection sous-cutanée ?\nComment reconnaître une réaction allergique à une injection ?\nQuels signes d'infection doivent alerter après une injection ?\nQuels symptômes peuvent indiquer une mauvaise technique d'injection ?\nQuels symptômes peuvent survenir en cas de lipodystrophie ?",
"url": "https://questionsmedicales.fr/mesh/D007279#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Injections sous-cutanées",
"description": "Comment prévenir les infections lors d'injections ?\nQuelles sont les bonnes pratiques d'injection sous-cutanée ?\nComment éviter les douleurs post-injection ?\nQuels conseils pour les patients sur les injections ?\nComment prévenir la lipodystrophie ?",
"url": "https://questionsmedicales.fr/mesh/D007279#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Injections sous-cutanées",
"description": "Comment traiter une réaction allergique à une injection ?\nQuel traitement pour une infection après injection ?\nComment gérer la douleur après une injection sous-cutanée ?\nQuels soins à apporter au site d'injection ?\nComment prévenir les complications après une injection ?",
"url": "https://questionsmedicales.fr/mesh/D007279#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Injections sous-cutanées",
"description": "Quelles sont les complications possibles des injections sous-cutanées ?\nComment reconnaître une lipodystrophie ?\nQuels sont les signes d'une infection grave après injection ?\nQuelles sont les conséquences d'une injection mal réalisée ?\nQuels risques sont associés à des injections répétées au même endroit ?",
"url": "https://questionsmedicales.fr/mesh/D007279#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Injections sous-cutanées",
"description": "Quels facteurs augmentent le risque d'infection après injection ?\nComment le diabète influence-t-il les injections sous-cutanées ?\nQuels médicaments augmentent le risque de complications ?\nQuel rôle joue l'âge dans les complications d'injection ?\nComment le surpoids affecte-t-il les injections sous-cutanées ?",
"url": "https://questionsmedicales.fr/mesh/D007279#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une réaction à une injection sous-cutanée ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un examen clinique et des antécédents médicaux sont nécessaires pour identifier les réactions."
}
},
{
"@type": "Question",
"name": "Quels tests peuvent évaluer l'efficacité d'une injection sous-cutanée ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins peuvent mesurer les niveaux de médicament après l'injection."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une infection au site d'injection ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Rougeur, chaleur, gonflement et douleur au site d'injection peuvent indiquer une infection."
}
},
{
"@type": "Question",
"name": "Comment évaluer une douleur persistante après injection ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une évaluation clinique est nécessaire pour déterminer la cause de la douleur persistante."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer une surdose par injection ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes tels que nausées, vertiges ou confusion peuvent indiquer une surdose."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont courants après une injection sous-cutanée ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Rougeur, légère douleur et gonflement au site d'injection sont fréquents."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une réaction allergique à une injection ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des démangeaisons, éruptions cutanées ou œdème peuvent signaler une allergie."
}
},
{
"@type": "Question",
"name": "Quels signes d'infection doivent alerter après une injection ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, pus ou douleur intense au site d'injection peuvent indiquer une infection."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer une mauvaise technique d'injection ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs intenses ou des hématomes peuvent signaler une mauvaise technique."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent survenir en cas de lipodystrophie ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des irrégularités cutanées ou des dépôts graisseux peuvent indiquer une lipodystrophie."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections lors d'injections ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des aiguilles stériles et désinfecter la peau avant l'injection est essentiel."
}
},
{
"@type": "Question",
"name": "Quelles sont les bonnes pratiques d'injection sous-cutanée ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Choisir le bon site, utiliser une technique appropriée et respecter l'hygiène sont cruciaux."
}
},
{
"@type": "Question",
"name": "Comment éviter les douleurs post-injection ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Changer régulièrement de site d'injection et utiliser des techniques douces peut aider."
}
},
{
"@type": "Question",
"name": "Quels conseils pour les patients sur les injections ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Informer les patients sur les signes d'infection et l'importance de l'hygiène est vital."
}
},
{
"@type": "Question",
"name": "Comment prévenir la lipodystrophie ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Alterner les sites d'injection et éviter les zones de lipodystrophie peut prévenir cette condition."
}
},
{
"@type": "Question",
"name": "Comment traiter une réaction allergique à une injection ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antihistaminiques ou des corticostéroïdes peuvent être administrés selon la gravité."
}
},
{
"@type": "Question",
"name": "Quel traitement pour une infection après injection ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antibiotiques peuvent être nécessaires pour traiter une infection au site d'injection."
}
},
{
"@type": "Question",
"name": "Comment gérer la douleur après une injection sous-cutanée ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analgésiques en vente libre peuvent aider à soulager la douleur post-injection."
}
},
{
"@type": "Question",
"name": "Quels soins à apporter au site d'injection ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est conseillé de garder le site propre et sec pour éviter les infections."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications après une injection ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser une technique stérile et éviter les zones à risque peut réduire les complications."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles des injections sous-cutanées ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent infections, hématomes, et réactions allergiques."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une lipodystrophie ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des irrégularités cutanées ou des dépôts graisseux au site d'injection peuvent indiquer une lipodystrophie."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'une infection grave après injection ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre élevée, rougeur intense et écoulement purulent peuvent indiquer une infection grave."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une injection mal réalisée ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une injection mal réalisée peut entraîner des douleurs, des hématomes ou des infections."
}
},
{
"@type": "Question",
"name": "Quels risques sont associés à des injections répétées au même endroit ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des injections répétées peuvent causer des cicatrices, des lipodystrophies ou des infections."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'infection après injection ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un système immunitaire affaibli, une mauvaise hygiène et des techniques inappropriées augmentent le risque."
}
},
{
"@type": "Question",
"name": "Comment le diabète influence-t-il les injections sous-cutanées ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les patients diabétiques peuvent avoir un risque accru d'infections et de complications cutanées."
}
},
{
"@type": "Question",
"name": "Quels médicaments augmentent le risque de complications ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anticoagulants et les immunosuppresseurs peuvent augmenter le risque de complications."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'âge dans les complications d'injection ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes âgées peuvent avoir une peau plus fragile, augmentant le risque de complications."
}
},
{
"@type": "Question",
"name": "Comment le surpoids affecte-t-il les injections sous-cutanées ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le surpoids peut rendre l'injection plus difficile et augmenter le risque de complications."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 30/01/2026
Contenu vérifié selon les dernières recommandations médicales
5 publications dans cette catégorie
Affiliations :
School of Mechanical Engineering, Purdue University, West Lafayette, IN 47906, United States. Electronic address: ardekani@purdue.edu.
Publications dans "Injections sous-cutanées" :
4 publications dans cette catégorie
Affiliations :
Mechanical Engineering, Purdue University, 585 Purdue Mall Purdue University West Lafayette, IND 47906, United States.
Publications dans "Injections sous-cutanées" :
4 publications dans cette catégorie
Affiliations :
Department of Industrial and Physical Pharmacy, Purdue University, West Lafayette, Indiana, USA.
Publications dans "Injections sous-cutanées" :
4 publications dans cette catégorie
Affiliations :
Department of Industrial and Physical Pharmacy, Purdue University, West Lafayette, Indiana, USA. tonglei@purdue.edu.
Publications dans "Injections sous-cutanées" :
3 publications dans cette catégorie
Affiliations :
Industrial & Physical Pharmacy, Purdue University West Lafayette, Indiana, USA.
Publications dans "Injections sous-cutanées" :
3 publications dans cette catégorie
Affiliations :
Industrial & Physical Pharmacy, Purdue University West Lafayette, Indiana, USA.
Publications dans "Injections sous-cutanées" :
2 publications dans cette catégorie
Affiliations :
School of Mechanical Engineering, Purdue University, West Lafayette, IN 47906, United States.
Publications dans "Injections sous-cutanées" :
2 publications dans cette catégorie
Affiliations :
Mechanical Engineering, Purdue University, 585 Purdue Mall Purdue University West Lafayette, IND 47906, United States.
Publications dans "Injections sous-cutanées" :
2 publications dans cette catégorie
Affiliations :
Mechanical Engineering, Purdue University, 585 Purdue Mall Purdue University West Lafayette, IND 47906, United States.
Publications dans "Injections sous-cutanées" :
2 publications dans cette catégorie
Affiliations :
College of Pharmacy, Kangwon National University, Chuncheon, Gangwon 24341, Republic of Korea.
Publications dans "Injections sous-cutanées" :
2 publications dans cette catégorie
Affiliations :
College of Pharmacy, Kangwon National University, Chuncheon, Gangwon 24341, Republic of Korea.
Publications dans "Injections sous-cutanées" :
2 publications dans cette catégorie
Affiliations :
College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, Republic of Korea.
Publications dans "Injections sous-cutanées" :
2 publications dans cette catégorie
Affiliations :
College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, Republic of Korea.
Publications dans "Injections sous-cutanées" :
2 publications dans cette catégorie
Affiliations :
College of Pharmacy, Kangwon National University, Chuncheon, Gangwon 24341, Republic of Korea. Electronic address: hjcho@kangwon.ac.kr.
Publications dans "Injections sous-cutanées" :
2 publications dans cette catégorie
Affiliations :
School of Mechanical Engineering, Purdue University, West Lafayette, IN 47907, United States of America.
Publications dans "Injections sous-cutanées" :
2 publications dans cette catégorie
Affiliations :
Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.
Publications dans "Injections sous-cutanées" :
2 publications dans cette catégorie
Affiliations :
Sanofi, Bridgewater, New Jersey, USA.
Publications dans "Injections sous-cutanées" :
2 publications dans cette catégorie
Affiliations :
Sanofi, Bridgewater, New Jersey, USA.
Publications dans "Injections sous-cutanées" :
2 publications dans cette catégorie
Affiliations :
College of Animal Science and Technology, Henan University of Science and Technology, Luoyang, China.
Publications dans "Injections sous-cutanées" :
2 publications dans cette catégorie
Affiliations :
College of Animal Science and Technology, Henan University of Science and Technology, Luoyang, China.
Publications dans "Injections sous-cutanées" :
Widespread use of subcutaneous injection for parenteral medications is likely to be related to high medication bioavailability and rapid onset of action. Correct subcutaneous injection technique and s...
The study aimed to determine nurses' knowledge and practice preferences regarding subcutaneous injection technique and administration site selection....
This cross-sectional study took place between March and June 2021....
This study included 289 nurses, willing to participate who worked in units performing subcutaneous injections in a university hospital in Turkey....
Most nurses reported their preferred administration site for subcutaneous injections was the lateral aspects of the upper arm. More than half of the nurses did not use a rotation chart, they swabbed t...
Nurse knowledge of best practice subcutaneous injection administration and site selection could be improved in line with current evidence to improve personcentred and quality and safe care delivery. F...
To construct a detailed mechanistic and physiologically based biopharmaceutics model capable of predicting 1) device-formulation-tissue interaction during the injection process and 2) binding, degrada...
A mathematical model, SubQ-Sim, was developed incorporating the details of the various substructures within the subcutaneous environment together with the calculation of dynamic drug disposition towar...
The model predicts the tissue backpressure time profile during the injection as a function of injection rate, volume injected, solution viscosity, and interstitial fluid viscosity. The shape of the de...
This novel model can successfully predict tissue back pressure, depot dimensions, drug and protein concentration and formulation losses due to incorrect injection, which are all important starting con...
Subcutaneous injection of monoclonal antibodies (mAbs) has experienced unprecedented growth in the pharmaceutical industry due to its benefits in patient compliance and cost-effectiveness. However, th...
Self-administered depot medroxyprogesterone acetate subcutaneous injectable contraception (DMPA-SC) is registered in many countries. It shows great potential for improving contraceptive access, contin...
To describe the implementation strategies to scale up self-administered DMPA-SC and the barriers, facilitators, and outcomes of these programs....
Recent guidelines, including the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) extension for scoping reviews, were used to design and report this review. An article or re...
Of the 755 retrieved documents, 34 were included in this review. Most of the documents included were multi-country reports (n = 14), and all documents were published within the last 5 years (2018-2021...
This scoping review reported a wide range of interventions employed by countries and programs to scale up DMPA-SC self-administration but minimal evidence of the scale-up outcomes. Evidence from this ...
The protocol for this review was registered in the protocols.io repository ( https://www.protocols.io/view/a-protocol-for-a-scoping-review-of-implementation-x54v9yemmg3e/v1 )....
The hormones used in fertility treatment come in various forms. Progesterone used for luteal phase support is often administered vaginally as either suppositories, tablets or gel. However, in Denmark ...
A qualitative study with online and face to face interviews with a total of 19 women undergoing an ART treatment. Only women with at least one previous blastocyst transfer using vaginal progesterone o...
The analysis resulted in four themes: (1) medication, (2) everyday life, (3) bodily experiences and (4) infertility or hope. Most informants highlighted the administration of subcutaneous progesterone...
The findings of this study suggest that the satisfaction with the subcutaneous progesterone is generally positive. However, valuable thoughts have given insights into possible areas, which could be im...
The development of new large molecule drug therapies along with the innovation of biologic-device combination products such as prefilled syringes, autoinjectors and pen injectors have significantly im...
The use of continuous subcutaneous insulin infusion (CSII) therapy in pregnancies affected by pregestational diabetes mellitus (DM) has generated mixed outcome data worthy of further investigation. Th...
A predefined, systematic, librarian-assisted search of MEDLINE (PubMed), Embase, Cochrane Library, Scopus, ClinicalTrials.gov, and World Health Organization International Clinical Trial Registry Platf...
Among 39 eligible studies, 39% of the 5518 pregnancies included were exposed to CSII. Odds of cesarean delivery were higher with CSII (20 studies: 63% vs 56%, odds ratio [OR] 1.3 [95% confidence inter...
Use of CSII (vs MDI) for pregestational DM in pregnancy is associated with higher odds of cesarean delivery and delivery of an LGA neonate. Further evaluation of how CSII use may influence neonatal si...
Self-administration of subcutaneous interferon beta-1a (sc IFN β-1a) can be achieved with the RebiSmart® electromechanical autoinjector. This study investigated adherence to, and duration of persisten...
This retrospective, observational study utilized data from RebiSmart® devices, recorded on the MSdialog database, between January 2014 and November 2019. Adherence and persistence were evaluated over ...
The population of RebiSmart® users (...
People living with MS were highly adherent to use of the RebiSmart® device, with higher persistence generally observed for older and/or male individuals....
In this randomized, double-blind, placebo-controlled study, we evaluated the efficacy of an individualized technique of subcutaneous injection of botulinum toxin type A (BoNT-A) targeted (SjBoT) to th...
Hyperglycemia is common and difficult to control in perioperative patients with type 2 diabetes mellitus (T2DM), which impacts their prognosis after operation. Our study investigated the short-term ef...
T2DM patients (...
Scale efficiencies of the CSII group with CCR model and BCC model were better than that of the MDI group. Regarding slack variables, with higher surgical levels, the CSII group was closer to the ideal...
CSII could effectively control blood glucose levels and shorten perioperative hospitalizing time for T2DM patients, indicating that CSII was beneficial in perioperative period and should be promoted c...